Phillips, M. J., Alese, O. B., Horvat, N. K., Greene, E., Gbolahan, O. B., Coleman, K., . . . Lesinski, G. B. XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial. Taylor & Francis Group.
Chicago Style (17th ed.) CitationPhillips, Maggie J., et al. XL888 and Pembrolizumab Modulate the Immune Landscape of Colorectal Tumors in a Phase Ib/II Clinical Trial. Taylor & Francis Group.
MLA (9th ed.) CitationPhillips, Maggie J., et al. XL888 and Pembrolizumab Modulate the Immune Landscape of Colorectal Tumors in a Phase Ib/II Clinical Trial. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.